Histamine-dependent prolongation by aldosterone of vasoconstriction in isolated small mesenteric arteries of the mouse

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 304, Issue 8, 2013, Pages

  Schjerning, Jeppe ^a   Uhrenholt, Torben R ^a   Svenningsen, Per ^a   Vanhoutte, Paul M ^b,c   Skøtt, Ole ^a   Jensen, Boye L ^a   Hansen, Pernille B L ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Endothelial function; Mast cells; Microcirculation; Mineralocorticoid

Indexed keywords

ALDOSTERONE; CIMETIDINE; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2; DACTINOMYCIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HISTAMINE; HISTAMINE H2 RECEPTOR; INDOMETACIN; MEPACRINE; MINERALOCORTICOID RECEPTOR; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; POTASSIUM ION; PROSTAGLANDIN SYNTHASE; TERUTROBAN; TOLONIUM CHLORIDE; UNCLASSIFIED DRUG; VALERYLSALICYLIC ACID; CALCIUM; CYCLOOXYGENASE 1; HISTAMINE H2 RECEPTOR ANTAGONIST; MEMBRANE PROTEIN; NOS3 PROTEIN, MOUSE; PTGS1 PROTEIN, MOUSE; PTGS2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL WALL; CELL ISOLATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; FEMALE; FLUORESCENCE MICROSCOPY; GRANULAR CELL; MALE; MAST CELL; MEDIATOR; MESENTERIC ARTERY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; STAINING; VASCULAR SMOOTH MUSCLE; VASCULAR SMOOTH MUSCLE CELL; VASOCONSTRICTION; VASODILATATION; WILD TYPE; ANIMAL; ARTERIOLE; C57BL MOUSE; GENETICS; METABOLISM; MICROCIRCULATION; MOUSE MUTANT; PHYSIOLOGY; TIME; VASCULAR ENDOTHELIUM;

ALDOSTERONE; ANIMALS; ARTERIOLES; CALCIUM; CIMETIDINE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ENDOTHELIUM, VASCULAR; FEMALE; HISTAMINE; HISTAMINE H2 ANTAGONISTS; MALE; MAST CELLS; MEMBRANE PROTEINS; MESENTERIC ARTERIES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROCIRCULATION; MICROSCOPY, CONFOCAL; NITRIC OXIDE SYNTHASE TYPE III; RECEPTORS, MINERALOCORTICOID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS; VASOCONSTRICTION; VASODILATION;

MLCS; MLOWN;

EID: 84878440985     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00524.2012     Document Type: Article

References (41)

1. Al-Mashhadi RH, Skøtt O, Vanhoutte PM, Hansen PB. Activation of A2 adenosine receptors dilates cortical efferent arterioles in mouse. Kidney Int 75: 793-799, 2009.
2. Andersson M, Nilsson U, Hjalmarsson C, Haraldsson B, Nyström JS. Mild renal ischemia-reperfusion reduces charge and size selectivity of the glomerular barrier. Am J Physiol Renal Physiol 292: F1802-F1809, 2007.
3. Arima S, Kohagura K, Xu HL, Sugawara A, Abe T, Satoh F, Takeuchi K, Ito S. Nongenomic vascular action of aldosterone in the glomerular microcirculation. J Am Soc Nephrol 14: 2255-2263, 2003.
4. Christ M, Meyer C, Sippel K, Wehling M. Rapid aldosterone signaling in vascular smooth muscle cells: involvement of phospholipase C, diacylglycerol and protein kinase C alpha. Biochem Biophys Res Commun 213: 123-129, 1995.
5. Daneshmand MA, Keller RS, Canver MC, Canver AC, Canver CC. Histamine H1 and H2 receptor-mediated vasoreactivity of human internal thoracic and radial arteries. Surgery 136: 458-463, 2004.
6. Diamant B, Krüger PG. Structural changes of isolated rat peritoneal mast cells induced by adenosine triphosphate and adenosine diphosphate. J Histochem Cytochem 16: 707-716, 1968.
7. Diamant B, Kruger PG, Uvans B. Local degranulation of individual rat peritoneal mast cells induced by compound 48-80. Acta Physiol Scand 79: 1-5, 1970.
8. Doyle MP, Linden J, Duling BR. Nucleoside-induced arteriolar constriction: a mast cell-dependent response. Am J Physiol Heart Circ Physiol 266: H2042-H2050, 1994.
9. Eto M, Kitazawa T, Yazawa M, Mukai H, Ono Y, Brautigan DL. Histamine-induced vasoconstriction involves phosphorylation of a specific inhibitor protein for myosin phosphatase by protein kinase C alpha and delta isoforms. J Biol Chem 276: 29072-29078, 2001.
10. Golestaneh N, Klein C, Valamanesh F, Suarez G, Agarwal MK, Mirshahi M. Mineralocorticoid receptor-mediated signaling regulates the ion gated sodium channel in vascular endothelial cells and requires an intact cytoskeleton. Biochem Biophys Res Commun 280: 1300-1306, 2001.
11. Grosman N. Comparison of the influence of NSAIDs with different COX-selectivity on histamine release from mast cells isolated from naïve and sensitized rats. Int Immunopharmacol 7: 532-540, 2007.
12. Hill SJ, Ganellin CR, Timmerman H, Schwartz JC, Shankley NP, Young JM, Schunack W, Levi R, Haas HL. International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmacol Rev 49: 253-278, 1997.
13. Inoue H, Nagata N, Koshihara Y. Inhibition by actinomycin D of neurogenic mouse ear oedema. Inflamm Res 44: 125-130, 1995.
14. Kitazawa T, Eto M, Woodsome TP, Brautigan DL. Agonists trigger G protein-mediated activation of the CPI-17 inhibitor phosphoprotein of myosin light chain phosphatase to enhance vascular smooth muscle contractility. J Biol Chem 275: 9897-9900, 2000.
15. Kornel L. Colocalization of 11 beta-hydroxysteroid dehydrogenase and mineralocorticoid receptors in cultured vascular smooth muscle cells. Am J Hypertens 7: 100-103, 1994.
16. Kratz A, Ferraro M, Sluss PM, Lewandrowski KB. Case records of the Massachusetts General Hospital weekly clinicopathological exercises. Laboratory reference values. N Engl J Med 351: 1548-1563, 2004.
17. Laukeviciene A, Ugincius P, Korotkich I, Lazauskas R, Kevelaitis E. Anaphylaxis of small arteries: putative role of nitric oxide and prostanoids. Medicina (Kaunas) 46: 38-44, 2010.
18. Lewis GP, Whittle BJ. The inhibition of histamine release from rat peritoneal mast cells by non-steroid anti-inflammatory drugs and its reversal by calcium. Br J Pharmacol 61: 229-235, 1977.
19. Liu SL, Schmuck S, Chorazcyzewski JZ, Gros R, Feldman RD. Aldosterone regulates vascular reactivity: short-term effects mediated by phosphatidylinositol 3-kinase-dependent nitric oxide synthase activation. Circulation 108: 2400-2406, 2003.
20. Manolopoulou J, Bielohuby M, Caton SJ, Gomez-Sanchez CE, Renner-Mueller I, Wolf E, Lichtenauer UD, Beuschlein F, Hoeflich A, Bidlingmaier M. A highly sensitive immunofluorometric assay for the measurement of aldosterone in small sample volumes: validation in mouse serum. J Endocrinol 196: 215-224, 2008.
21. McCurley A, Pires PW, Bender SB, Aronovitz M, Zhao MJ, Metzger D, Chambon P, Hill MA, Dorrance AM, Mendelsohn ME, Jaffe IZ. Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors. Nat Med 18: 1429-1433, 2012.
22. Mehdi UF, Adams-Huet B, Raskin P, Vega GL, Toto RD. Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy. J Am Soc Nephrol 20: 2641-2650, 2009.
23. 2+ levels, and vasoconstriction in mesenteric resistance vessels. Endocrinology 146: 973-980, 2005.
24. Nguyen Dinh Cat A, Griol-Charhbili V, Loufrani L, Labat C, Benjamin L, Farman N, Lacolley P, Henrion D, Jaisser F. The endothelial mineralocorticoid receptor regulates vasoconstrictor tone and blood pressure. FASEB J 24: 2454-2463, 2010.
25. Payne GW, Madri JA, Sessa WC, Segal SS. Abolition of arteriolar dilation but not constriction to histamine in cremaster muscle of eNOS-/-mice. Am J Physiol Heart Circ Physiol 285: H493-H498, 2003.
26. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341: 709-717, 1999.
27. Schjoedt KJ, Andersen S, Rossing P, Tarnow L, Parving HH. Aldosterone escape during blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate. Diabetologia 47: 1936-1939, 2004.
28. Schneider A, Riess P, Elbers A, Neugebauer E, Schaefer U. Polyclonal anti-histamine H2 receptor antibodies detect differential expression of H2 receptor protein in primary vascular cell types. Inflamm Res 53: 223-229, 2004.
29. Shahinian HK, Ferguson MK, Michelassi F. Effect of histamine and histamine receptor antagonists on rat mesenteric microcirculation. J Surg Res 42: 703-707, 1987.
30. Shepherd RK, Duling BR. Inosine-induced vasoconstriction is mediated by histamine and thromboxane derived from mast cells. Am J Physiol Heart Circ Physiol 270: H560-H566, 1996.
31. Simonet S, Descombes JJ, Vallez MO, Dubuffet T, Lavielle G, Verbeuren TJ. S 18886, a new thromboxane (TP)-receptor antagonist is the active isomer of S 18204 in all species, except in the guinea-pig. In: Recent Advances in Prostaglandin, Thromboxane, and Leukotriene Research, edited by Sinzinger H, Samuelson B, Vane JR, Paoletti R, Ramwell P, Wong PY-K. Plenum Press, 1998.
32. Skøtt O, Uhrenholt TR, Schjerning J, Hansen PB, Rasmussen LE, Jensen BL. Rapid actions of aldosterone in vascular health and disease-friend or foe? Pharmacol Ther 111: 495-507, 2006.
33. Swedberg K, Eneroth P, Kjekshus J, Wilhelmsen L. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. Circulation 82: 1730-1736, 1990.
34. Tang EH, Feletou M, Huang Y, Man RY, Vanhoutte PM. Acetylcholine and sodium nitroprusside cause long-term inhibition of EDCF-mediated contractions. Am J Physiol Heart Circ Physiol 289: H2434-H2440, 2005.
35. Tatham PE, Duchen MR, Millar J. Monitoring exocytosis from single mast cells by fast voltammetry. Pflügers Arch 419: 409-414, 1991.
36. Uhrenholt TR, Domeier TL, Segal SS. Propagation of calcium waves along endothelium of hamster feed arteries. Am J Physiol Heart Circ Physiol 292: H1634-H1640, 2007.
37. Uhrenholt TR, Schjerning J, Hansen PB, Nørregaard R, Jensen BL, Sorensen GL, Skøtt O. Rapid inhibition of vasoconstriction in renal afferent arterioles by aldosterone. Circ Res 93: 1258-1266, 2003.
38. Uhrenholt TR, Schjerning J, Vanhoutte PM, Jensen BL, Skøtt O. Intercellular calcium signaling and nitric oxide feedback during constriction of rabbit renal afferent arterioles. Am J Physiol Renal Physiol 292: F1124-F1131, 2007.
39. Van de Voorde J, Delaey C, Depypere H, Vanheel B. Mechanisms involved in the vasorelaxing influence of histamine on isolated human subcutaneous resistance arteries. Eur J Pharmacol 349: 61-66, 1998.
40. Wang XS, Lau HY. Prostaglandin E potentiates the immunologically stimulated histamine release from human peripheral blood-derived mast cells through EP1/EP3 receptors. Allergy 61: 503-506, 2006.
41. Xavier FE, Aras-López R, Arroyo-Villa I, Campo LD, Salaices M, Rossoni LV, Ferrer M, Balfagón G. Aldosterone induces endothelial dysfunction in resistance arteries from normotensive and hypertensive rats by increasing thromboxane A2 and prostacyclin. Br J Pharmacol 154: 1225-1235, 2008.